Park Medi World
- Market cap
- ₹ 9,276 Cr.
- P/E
- 35.3x
- P/B
- 4.65x
- 52-week range
- 138.1 – 305
- ROE
- 17%
- ROCE
- 19%
- Debt / equity
- 0.18
- Sector
- Healthcare Services
- Industry
- Hospital
- Listed on
- NSE, BSE
About
Park Medi World Limited is an India-based company, which operates a private hospital chain in North India. It operates a network of over 13 National Accreditation Board for Hospitals & Healthcare Providers (NABH) accredited multi-super specialty hospitals under the Park brand, of which seven hospitals are also NABL accredited, with eight hospitals in Haryana, one hospital in New Delhi, two hospitals in Punjab and two hospitals in Rajasthan. It offers over 30 super specialty and specialty services, including internal medicine, neurology, urology, gastroenterology, cardiology, general surgery, orthopedics and oncology. Its specialties include cardiac sciences, neurosciences - brain & spine, plastic & cosmetic surgery, general and laparoscopic surgery, renal sciences & kidney transplant, and others. Its multi specialties include bariatric surgery, anesthesiology, critical care, chest & respiratory diseases, dermatology, endocrinology, internal medicine & geriatrics, and others.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Hospital: 41 companies →Park Medi World against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)35.3 against a typical 48.6: cheaper than most peers (1st = cheapest).14th of 40
- Sales growth+19.3% against a typical +21.1% from a year earlier.19th of 34
- Profit growth+34.8% against a typical +13% from a year earlier.10th of 31
- Share price, 3 months−19.1% against a typical −10.9%.26th of 34
- Size₹ 9,275.5 Cr. market value against a typical ₹ 1,306.7 Cr. (1st = largest).11th of 36
Latest announcements
Exchange filings and their impact on the company.
- Income Tax verification at some sites, operations unaffected; watch for any tax demand.
Park Medi World said the Income Tax Department conducted verification at some premises of the company and some subsidiaries. The company said its officials cooperated and that there is no impact on operational performance. No tax demand, seizure or other financial amount was disclosed, so the near-term impact is limited to possible legal costs and any future demand if raised.
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 3 Aug 2026 | Financial Results/Other business matters | To consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter ended June 30, 2026 and other business matters |
| 12 May 2026 | Financial Results | To consider and approve the standalone and consolidated audited financial results of the Company for the quarter and year ended on March 31, 2026. |
| 28 Jan 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 348 | 354 | 399 | 410 | 410 | 460 | 476 |
| Expenses | 265 | 265 | 294 | 297 | 311 | 333 | 350 |
| Operating Profit | 83 | 88 | 105 | 113 | 99 | 127 | 126 |
| OPM % | 24% | 25% | 26% | 27% | 24% | 28% | 26% |
| Other Income | 15 | 9 | 7 | 8 | 9 | 8 | 8 |
| Interest | 16 | 16 | 15 | 15 | 15 | 14 | 10 |
| Depreciation | 15 | 16 | 15 | 15 | 15 | 18 | 19 |
| Profit before tax | 67 | 66 | 82 | 91 | 78 | 103 | 105 |
| Tax % | 32% | 20% | 20% | 14% | 32% | 26% | 16% |
| Net Profit | 46 | 52 | 66 | 79 | 53 | 77 | 89 |
| EPS in Rs | 2.97 | 1.17 | 1.51 | 1.91 | 1.17 | 1.64 | 1.91 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 17%
- 3 Years
- 10%
- TTM
- 21%
- 10 Years
- —
- 5 Years
- 11%
- 3 Years
- 5%
- TTM
- 25%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
- 10 Years
- —
- 5 Years
- 24%
- 3 Years
- 19%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Park Medi World | ₹ 226.00 | ₹ 9,276 Cr. | 35.3x | 4.7x | 17% | — |
| Apollo Hospitals Enterprise | ₹ 7,731.95 | ₹ 1,11,174 Cr. | 64.9x | 13.4x | 22% | 7.8% |
| Max Healthcare Institute | ₹ 817.00 | ₹ 79,519 Cr. | 71.5x | 9.9x | 14.3% | 17.2% |
| Fortis Healthcare | ₹ 720.00 | ₹ 54,357 Cr. | 67.9x | 7.3x | 11.1% | 11.7% |
| Aster DM Healthcare | ₹ 651.00 | ₹ 56,817 Cr. | 102.6x | 9.3x | 9.7% | 9.2% |
| Narayana Hrudayalaya | ₹ 1,667.25 | ₹ 33,862 Cr. | 48.1x | 9.1x | 19.9% | 10.3% |
Management
- Ajit Gupta
- Chairman and Whole Time Director
- Sanjay Sharma
- Whole Time Director, Chief Executive Officer
- Abhishek Kapoor
- Company Secretary, Compliance Officer
- Ankit Gupta
- Managing Director, Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.